Detection of anti-infliximab antibodies is of limited value to predict acquired drug resistance to infliximab in rheumatoid arthritis

被引:0
|
作者
Finckh, Axel [1 ]
Dudler, Jean [2 ]
Wennelinger, Felix [3 ]
Ciurca, Adrian [4 ]
Gabay, Cem [1 ]
Bas, Sylvette [1 ]
机构
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Univ Lausanne Hosp, Lausanne, Switzerland
[3] Univ Hosp Bern, CH-3010 Bern, Switzerland
[4] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
来源
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S777 / S777
页数:1
相关论文
共 50 条
  • [21] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [22] Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Bray, Kurtis R.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Snapper, Scott B.
    Bousvaros, Athos
    Silvester, Jocelyn A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (02): : 261 - 271
  • [23] The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure
    Krintel, Sophine B.
    Grunert, Veit Peter
    Hetland, Merete L.
    Johansen, Julia S.
    Rothfuss, Matthias
    Palermo, Giuseppe
    Essioux, Laurent
    Klause, Ursula
    RHEUMATOLOGY, 2013, 52 (07) : 1245 - 1253
  • [24] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    van der Maas, Aatke
    van den Bemt, Bart J. F.
    Wolbink, Gertjan
    van den Hoogen, Frank H. J.
    van Riel, Piet L. C. M.
    den Broeder, Alfons A.
    BMC MUSCULOSKELETAL DISORDERS, 2012, 13
  • [25] Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
    Aatke van der Maas
    Bart JF van den Bemt
    Gertjan Wolbink
    Frank HJ van den Hoogen
    Piet LCM van Riel
    Alfons A den Broeder
    BMC Musculoskeletal Disorders, 13
  • [26] ANTI-INFLIXIMAB ANTIBODIES IMPAIR CLINICAL RESPONSE TO INFLIXIMAB IN JIA ASSOCIATED UVEITIS
    Metha, R.
    Tay-Kearney, M.
    Manners, P.
    Murray, K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 32 - 33
  • [27] Infusion reactions during infliximab treatment are not associated with IgE anti-infliximab antibodies
    van Schie, Karin A.
    Heer, Pleuni Ooijevaar-De
    Kruithof, Simone
    Plasencia, Chamaida
    Jurado, Teresa
    Salcedo, Dora Pascual
    Brandse, Johannan F.
    d'Haens, Geert R. A. M.
    Wolbink, Gerrit Jan
    Rispens, Theo
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (07) : 1285 - 1288
  • [28] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
    Steenholdt, C.
    Brynskov, J.
    Bendtzen, K.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 499 - 500
  • [29] Anti-infliximab antibodies in patients with an infusion-related allergic response to infliximab
    Wolbink, GJ
    De Groot, E
    Lems, WF
    Nurmohamed, MT
    Tak, PP
    Dijkmans, BAC
    Voskuyl, AE
    Aarden, L
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 179 - 179
  • [30] Letter: detection of infliximab levels and anti-infliximab antibodies - comparison of three different assays; authors' reply
    Buurman, D. J.
    Vande Casteele, N.
    Sturkenboom, M. G. G.
    Kleibeuker, J. H.
    Vermeire, S.
    van der Kleij, D.
    Rispens, T.
    Gils, A.
    Dijkstra, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (02) : 282 - 282